Qisheng Su

616 total citations
45 papers, 437 citations indexed

About

Qisheng Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Qisheng Su has authored 45 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Qisheng Su's work include Ferroptosis and cancer prognosis (9 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (6 papers). Qisheng Su is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (6 papers). Qisheng Su collaborates with scholars based in China, United States and Myanmar. Qisheng Su's co-authors include Fangwei Wang, Chaoqian Li, Xiaohong Li, Zheng Yang, Wuning Mo, Yuling Qiu, Gaozheng Zhao, Yuhua Yang, Jingyuan Cai and Yuqi Hu and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Qisheng Su

42 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qisheng Su China 12 173 105 94 66 52 45 437
Marco Müller Germany 11 90 0.5× 46 0.4× 120 1.3× 105 1.6× 41 0.8× 24 432
Xiaojiang Duan China 16 158 0.9× 69 0.7× 163 1.7× 175 2.7× 78 1.5× 51 644
Matthew S. Crowe United States 4 291 1.7× 120 1.1× 119 1.3× 220 3.3× 62 1.2× 8 691
Liting Jin China 7 193 1.1× 115 1.1× 71 0.8× 143 2.2× 40 0.8× 11 456
Hongwei Guan China 14 315 1.8× 80 0.8× 84 0.9× 66 1.0× 121 2.3× 35 655
Anatoly N. Pinchuk United States 10 196 1.1× 51 0.5× 125 1.3× 116 1.8× 145 2.8× 20 765
Chengxin Liu China 13 134 0.8× 89 0.8× 148 1.6× 98 1.5× 47 0.9× 59 558
Ze Gong China 7 250 1.4× 125 1.2× 101 1.1× 35 0.5× 97 1.9× 10 532
Veronica J. James Australia 14 189 1.1× 30 0.3× 55 0.6× 52 0.8× 45 0.9× 51 557

Countries citing papers authored by Qisheng Su

Since Specialization
Citations

This map shows the geographic impact of Qisheng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qisheng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qisheng Su more than expected).

Fields of papers citing papers by Qisheng Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qisheng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qisheng Su. The network helps show where Qisheng Su may publish in the future.

Co-authorship network of co-authors of Qisheng Su

This figure shows the co-authorship network connecting the top 25 collaborators of Qisheng Su. A scholar is included among the top collaborators of Qisheng Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qisheng Su. Qisheng Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Qisheng, et al.. (2025). ISACL: Internal State Analyzer for Copyrighted Training Data Leakage. 10786–10807.
2.
Liao, John B., et al.. (2025). The Role of SWI/SNF Complex in Bladder Cancer. Journal of Cellular and Molecular Medicine. 29(1). e70348–e70348. 2 indexed citations
3.
Yang, Xiaomin, Shuting Cheng, Wenjuan Li, et al.. (2025). Conformal hexagonal boron nitride encapsulation of graphene-skinned glass fiber fabric for enhanced electrical stability. Nature Communications. 16(1). 4965–4965. 2 indexed citations
4.
Yu, Chaojie, Wenjuan Li, Fushun Liang, et al.. (2025). Rapid preparation of graphene-skinned alumina fiber fabric and its electromagnetic interference shielding application. Nano Research. 18(5). 94907330–94907330. 2 indexed citations
5.
6.
Liu, Haodong, et al.. (2025). Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in erythroblasts. Annals of Hematology. 104(4). 2207–2219. 1 indexed citations
7.
An, Xin, et al.. (2023). Histone modification: Biomarkers and potential therapies in colorectal cancer. Annals of Human Genetics. 87(6). 274–284. 16 indexed citations
8.
Wang, Fangwei, et al.. (2022). Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma. World Journal of Surgical Oncology. 20(1). 275–275. 79 indexed citations
9.
Su, Qisheng, et al.. (2022). Systemic analysis the expression, prognostic, and immune infiltrates significance of MS4A family in lung cancer. All Life. 15(1). 134–146. 1 indexed citations
10.
Yang, Zheng, Shengqi Li, Huaying Liu, et al.. (2022). Identification of key genes and pathways associated with diabetes of the exocrine pancreas. Medicine. 101(34). e29781–e29781. 2 indexed citations
11.
Su, Qisheng, et al.. (2021). Mangiferin Inhibits Human Lung Adenocarcinoma by Suppressing MiR-27b and MiR-92a. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 6 indexed citations
12.
Su, Qisheng, et al.. (2021). A New Stemness‐Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma. BioMed Research International. 2021(1). 6669570–6669570. 5 indexed citations
13.
Zhang, Liqian, et al.. (2020). SDF2L1 Inhibits Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma. BioMed Research International. 2020(1). 1970936–1970936. 6 indexed citations
14.
Xiao, Huan, Qisheng Su, & Chaoqian Li. (2020). Identification of prognostic immune genes in laryngeal cancer. Journal of International Medical Research. 48(11). 1220764214–1220764214. 6 indexed citations
15.
Ma, Chao, et al.. (2020). <p>Curcumin Has Anti-Proliferative and Pro-Apoptotic Effects on Tongue Cancer in vitro: A Study with Bioinformatics Analysis and in vitro Experiments</p>. Drug Design Development and Therapy. Volume 14. 509–518. 25 indexed citations
16.
Yang, Zheng, Xiaohong Li, Qisheng Su, et al.. (2020). TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma. BioMed Research International. 2020(1). 3962146–3962146. 11 indexed citations
17.
Su, Qisheng, et al.. (2019). Low serum bilirubin, albumin, and uric acid levels in patients with Crohn's disease. Medicine. 98(19). e15664–e15664. 27 indexed citations
18.
Liu, Qie, Yongqian Zhang, Zhiyuan Song, et al.. (2009). A Simple and Rapid Method for the Determination of Pennogenin Diglycoside in Rat Plasma by HPLC-MS: Application to the Pharmacokinetics of the Extract in Gongxuening Capsules. Journal of Chromatographic Science. 47(8). 728–732. 4 indexed citations
19.
Su, Qisheng, et al.. (2000). Synthesis, structure and spectroscopic properties of an o-phthalate-bridged copper(II) chain complex. Journal of Molecular Structure. 516(2-3). 231–236. 24 indexed citations
20.
Su, Qisheng, et al.. (1999). Phosphors Doped with Dy<sup>3+</sup> and Gd <sup>3+</sup> for Lighting. Materials science forum. 315-317. 228–235. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026